Literature DB >> 20352356

Primary and secondary analysis of local elected officials' decisions to support or oppose pharmacy sale of syringes in California.

Glenn Backes1, Valerie J Rose.   

Abstract

Under California law, local governments may authorize pharmacies within their jurisdictions to sell ten or fewer syringes to an adult without prescription, proof of identity, or proof of medical need. Local governments may simultaneously exempt adults from prosecution for violation of state drug paraphernalia codes for possession of ten or fewer syringes for personal use. Both of these provisions are temporary and sunset on December 31, 2010, unless subsequent state legislation amends that date. The objective of our study was to ascertain how and why local policymakers made their decisions regarding non-prescription syringe sale (NPSS). We examined influences on their decisions, including specific messengers and the arguments that were most salient to their decision making. We selected jurisdictions that were geographically representative of California counties; those with and without syringe exchange programs, and those that had passed or rejected NPSS. We conducted nine semi-structured interviews in five jurisdictions. To enrich primary data collection, we analyzed secondary data by reviewing audio, video, and written transcripts of public hearings and newspaper coverage in five jurisdictions, including three jurisdictions without primary interview data. Among proponents of NPSS, we identified common themes, including: (1) public health research provided conclusive evidence for reduction in HIV and hepatitis transmission without problems of crime, drug use, or unsafe discard of syringes; (2) the local health officer was the key to influencing local policymakers; (3) recall of prior debates over syringe exchange served to inform their decision making; and (4) a lack of local opposition or controversy. Common concerns among opponents of NPSS included: (1) that there would be an increase in unsafe discard of syringes; (2) loss of an important law enforcement tool; (3) that drug users were incapable of desired behavior change; and (4) that research was inconclusive, or proved that syringe access would not work in reducing rates of disease. Themes held in common by proponents and opponents of NPSS were identified as well. Syringe access through NPSS is in fact supported by a robust body of public health research and is considered an important component of a comprehensive strategy to reduce HIV and hepatitis transmission. Our study highlights the importance of understanding the perspectives of elected officials in order to ameliorate their concerns without undermining the public health goal of reducing death, disease, and suffering in at-risk communities.

Entities:  

Mesh:

Year:  2010        PMID: 20352356      PMCID: PMC2900575          DOI: 10.1007/s11524-010-9442-8

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  4 in total

1.  Impact of increased syringe access: preliminary findings on injection drug user syringe source, disposal, and pharmacy sales in Harlem, New York.

Authors:  Crystal M Fuller; Jennifer Ahern; Liza Vadnai; Phillip O Coffin; Sandro Galea; Stephanie H Factor; David Vlahov
Journal:  J Am Pharm Assoc (Wash)       Date:  2002 Nov-Dec

2.  Non-prescription syringe sales in California: a qualitative examination of practices among 12 local health jurisdictions.

Authors:  Valerie J Rose; Glenn Backes; Alexis Martinez; Willi McFarland
Journal:  J Urban Health       Date:  2010-07       Impact factor: 3.671

3.  Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City.

Authors:  Crystal M Fuller; Sandro Galea; Wendy Caceres; Shannon Blaney; Sarah Sisco; David Vlahov
Journal:  Am J Public Health       Date:  2006-11-30       Impact factor: 9.308

4.  The impact of needle-exchange programs on the spread of HIV among injection drug users: a simulation study.

Authors:  J M Raboud; M C Boily; J Rajeswaran; M V O'Shaughnessy; M T Schechter
Journal:  J Urban Health       Date:  2003-06       Impact factor: 3.671

  4 in total
  3 in total

1.  Evaluating a statewide pilot syringe access program for injection drug users through pharmacies in California.

Authors:  Alex H Kral; Richard S Garfein
Journal:  J Urban Health       Date:  2010-07       Impact factor: 3.671

2.  Extent and patterns of community collaboration in local health departments: An exploratory survey.

Authors:  James Studnicki; Elena A Platonova; Chris N Eiechelberger; John W Fisher
Journal:  BMC Res Notes       Date:  2011-10-07

3.  Predictors of historical change in drug treatment coverage among people who inject drugs in 90 large metropolitan areas in the USA, 1993-2007.

Authors:  Barbara Tempalski; Leslie D Williams; Brooke S West; Hannah L F Cooper; Stephanie Beane; Umedjon Ibragimov; Samuel R Friedman
Journal:  Subst Abuse Treat Prev Policy       Date:  2020-01-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.